UnitedHealth Group (NYSE:UNH) Price Target Cut to $350.00 by Analysts at Barclays

UnitedHealth Group (NYSE:UNH) had its target price cut by Barclays to $350.00 in a research note published on Monday,Benzinga reports. They currently have an overweight rating on the healthcare conglomerate’s stock.

Several other research firms have also commented on UNH. Robert W. Baird lowered their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Finally, Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $439.17.

UnitedHealth Group Stock Up 0.8%

UNH stock opened at $304.27 on Monday. The company has a market cap of $276.01 billion, a P/E ratio of 19.63, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 52 week low of $248.88 and a 52 week high of $630.73. The company’s 50-day moving average price is $426.60 and its 200 day moving average price is $490.74. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the firm posted $6.91 EPS. On average, research analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Institutional investors have recently modified their holdings of the business. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $28,000. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.